Some industries have escaped these moves by the administration, at least for now. One of them is the pharmaceutical industry.

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S.

Trump doubled down on plans to soon impose “major” pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.

David Ricks is the CEO of Eli Lilly, the most valuable drugmaker in the world by market capitalization. Lilly is on the path to become the first trillion-dollar pharma company, fueled by the ...

However, some major executives in the sector are not optimistic, including Eli Lilly's (NYSE: LLY) CEO, David Ricks. Let's see what he had to say about the potential impact of tariffs, and what ...

However, some major executives in the sector are not optimistic, including Eli Lilly's (NYSE: LLY) CEO, David Ricks. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every ...